The findings could foreshadow the performance of accountable care organizations (ACOs), since the PGPD pilot also allowed physicians to share in savings if they could lower costs while improving quality and care coordination.
The three ACO pilots now underway were included in the Affordable Care Act in part because of promising results from the PGPD. Under the PGPD, 10 physician practices could earn up to 80% of any savings to the Medicare program, provided they generated at least 2% in savings.
While the savings for Medicare-only beneficiaries were small, the PGPD sites did well at reducing costs for dual-eligible beneficiaries, according to the study.
The PGPD practices also had lower 30-day hospital readmission rates on average for medical reasons and lower readmissions for both medical and surgical admissions among dual-eligible beneficiaries, according to the study.
The researchers also found significant variation in how each PGPD site performed, which also could hold clues for future ACO success.
Part A Deionized water 66.75 Panthenol 0.50 Tetrasodium EDTA 0.25 Schercotaine CAB (Scher) 20.00 Schercotaine SCAB (Scher) 5.00 Schercoquat IALA (Scher) 0.50 (isostearamidopropyl lauryl- acetodimonium chloride) Hydramol PGPD (Scher) 4.00 (PEG-8 PPG-3 diisostearate) Germaben II 1.00 Part B Sodium myreth sulfate (60%) 1.50 (Cognis) Fragrance 0.50
Hydramol PGPD acts as an effective additive for increasing the viscosity of surfactant-based systems at levels of 15% in combination with betaines, amine oxides and sultaines.
2: Viscosity Building Characteristics of Hydramol PGPD A.
Part A Deionized water 50.00 Citric Acid-USP (50% sol.) 0.05 Sequestrene 30A 0.05 dl-Panthenol 0.50 Sodium laureth sulfate 42.00 Hydramol PGPD (Scher) 2.00 (PEG-8, PPG-3 diisostearate) Hydramol PGDS (Scher) 1.80 (PEG-90 diisostearate) Part B Schercoquat RCIA 0.60 (isostearyl ricinoleamidopropyl betainate chloride) Fragrance q.s.